MAAT INDEX

CLAIM #58827 · UnitedHealth Group Incorporated (UNH) · 2025Q1 earnings call · Apr 17, 2025 · due Dec 31, 2026

we're committed to improving our performance in the rest of 2025 and into ‘26. And in doing so to delivering consistent positive results for you and returning to our long term earnings per share growth target of 13% to 16%.

Andrew Witty · CEO

PENDING
graded after results covering Dec 31, 2026 are reported

How to check this claim

Look at: Adjusted (or GAAP) diluted earnings per share year-over-year growth rate, annual

It came true if: Full-year EPS growth rate falls within 13%-16% (or returns to that range) for fiscal year 2026

Where: UnitedHealth Group 10-K / Q4 earnings release and management commentary on FY2026 results

In context

or our revenue cycle management customers. Lastly, Optum Rx revenues grew 14%, exceeding $35 billion for the quarter. Both customer retention and new customer wins contributed to script growth of 3%. As Andrew noted, performance in the quarter was below the standards we expect. But with disciplined and urgent execution and attention to detail, we expect a return to form in the quarters ahead. With that, I'll hand it back to Andrew. Andrew Witty : Thanks, John. Even with the growth of our -- I'm sorry. Even with the growth our people generated this quarter, this was far from the performance we expect of ourselves. We're acutely aware it's a privilege to be a part of an organization with the capabilities to make a meaningful contribution to modernizing and simplifying the health system. And we're committed to improving our performance in the rest of 2025 and into ‘26. And in doing so to delivering consistent positive results for you and returning to our long term earnings per share growth target of 13% to 16%. With that, we can now turn to your questions. Operator? Operator: [Operator Instructions] We'll take our first question from Justin Lake with Wolfe Research. Justin Lake : Thanks. Good morning. My question is on Medicare Advantage cost trend. You said that you came into the year assuming trend at similar levels 2024. Can you share with us precisely what that trend estimate was? Meaning, what did you expect for this year? And what are you expecting now? And can you tell us how much of that you actually saw in the first quarter? For instance, how much did you miss your MLR by, your own estimate of MLR? And how much you are expecting that to accelerate or how different the back three quarters is versus what you saw in the first quarter? Maybe I’ll jump the margin on the -- Andrew Witty : Yea

Verify independently

SEC filings for UNH · Claim quote is verbatim from the 2025Q1 earnings call.